‘U’r-in(e)!—urine albumin-creatinine ratio: the old kid on a new block! - Summary - MDSpire

‘U’r-in(e)!—urine albumin-creatinine ratio: the old kid on a new block!

  • By

  • Yakubu Bene-Alhasan

  • Vijay Nambi

  • Christie Ballantyne

  • February 9, 2026

  • 0 min

Share

Objective:

To emphasize the importance of longitudinal urine albumin-to-creatinine ratio (UACR) measurements in cardiovascular disease (CVD) risk assessment, highlighting their role in identifying high-risk individuals.

Key Findings:
  • Three distinct UACR trajectories were identified: slow rise at low level, slow rise at medium level, and sustained medium to high over 5 years; slow rise at low level, slow rise at medium level, and rapid rise over 10 years.
  • High-risk UACR trajectories were associated with significantly increased risks of heart failure, atrial fibrillation, and coronary heart disease.
  • Even participants with normal baseline UACR showed worse outcomes if they had a high-risk trajectory, indicating the need for repeat measurements.
Interpretation:

Longitudinal UACR measurements provide critical prognostic information that single-time-point assessments may overlook, particularly in identifying high-risk individuals and understanding disease progression.

Limitations:
  • The study's findings may not be generalizable to all populations due to demographic variations, such as age, sex, and ethnicity.
  • Potential confounding factors, such as comorbidities and lifestyle factors, were not fully addressed, which may influence the associations observed.
Conclusion:

Routine serial UACR measurements can enhance cardiovascular risk stratification and preventive care, especially since albuminuria is treatable, thereby improving patient outcomes.

Original Source(s)

Related Content